Mengchen Shi

Guangzhou, 510655, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion.

Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion.

Journal: Chinese medical journal

Published: December 26, 2024

Targeting gut microbiota and arginase boosts MEK inhibitors' enhancement of antitumour immunity via MHC-I upregulation in colorectal cancer.

Targeting gut microbiota and arginase boosts MEK inhibitors' enhancement of antitumour immunity via MHC-I upregulation in colorectal cancer.

Journal: British journal of cancer

Published: December 24, 2024

NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90α/EZH2/CXCL9 axis in colon cancer.

NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90α/EZH2/CXCL9 axis in colon cancer.

Journal: International immunopharmacology

Published: December 05, 2024

Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I.

Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I.

Journal: Journal of translational medicine

Published: May 20, 2024

Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-κB pathways.

Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-κB pathways.

Journal: European journal of pharmacology

Published: January 03, 2024

Tumor derived exosomal ENTPD2 impair CD8+ T cell function in colon cancer through ATP-adenosine metabolism reprogramming.

Tumor derived exosomal ENTPD2 impair CD8+ T cell function in colon cancer through ATP-adenosine metabolism reprogramming.

Journal: Cell communication and signaling : CCS

Published: November 09, 2023

HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, -10 and -11.

HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, -10 and -11.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 16, 2023

Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma.

Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma.

Journal: Journal of translational medicine

Published: May 25, 2023

Knockdown LIMP2 inhibits colorectal cancer cells migration, invasion, and metastasis.

Knockdown LIMP2 inhibits colorectal cancer cells migration, invasion, and metastasis.

Journal: Experimental cell research

Published: May 10, 2023

Jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer.

Jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer.

Journal: Biomolecules & biomedicine

Published: May 05, 2023

Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells.

Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells.

Journal: Nature communications

Published: March 31, 2023

Evacetrapib Elicits Antitumor Effects on Colorectal Cancer by Inhibiting the Wnt/β-Catenin Signaling Pathway and Activating the JNK Signaling Pathway.

Evacetrapib Elicits Antitumor Effects on Colorectal Cancer by Inhibiting the Wnt/β-Catenin Signaling Pathway and Activating the JNK Signaling Pathway.

Journal: Biological & pharmaceutical bulletin

Published: September 01, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026